Gsa Capital Partners LLP Sight Sciences, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.19 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023
SELL
$2.88 - $8.8 $696 - $2,129
-242 Reduced 1.17%
20,386 $68,000
Q2 2023

Aug 14, 2023
BUY
$7.46 - $10.67 $65,424 - $93,575
8,770 Added 73.96%
20,628 $170,000
Q1 2023

May 12, 2023
BUY
$8.44 - $13.35 $100,081 - $158,304
11,858 New
11,858 $103,000
Q3 2022

Nov 14, 2022
BUY
$6.1 - $11.41 $133,651 - $249,993
21,910 Added 92.05%
45,712 $290,000
Q2 2022

Aug 09, 2022
BUY
$6.61 - $11.99 $157,331 - $285,385
23,802 New
23,802 $214,000

Others Institutions Holding SGHT

# of Institutions
69
Shares Held
21.1M
Call Options Held
33.2K
Put Options Held
27.7K
View Full List

About Sight Sciences, Inc.

SGHT Quotes by TradingView
  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $296M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email